Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bernhardt

Showing results (161-170 of 224) with videos related to

Pageof 23
Sort By:
World Journal of Surgery|January 13, 2010
[177Lu-DOTA 0-Tyr 3]-octreotate treatment in patients with disseminated gastroenteropancreatic neuroendocrine tumors: the value of measuring absorbed dose to the kidneyChristina Swärd, Peter Bernhardt, Håkan Ahlman, et al.
Scientific Reports|November 30, 2019
Alpha-PET for Prostate Cancer: Preclinical investigation using <sup>149</sup>Tb-PSMA-617Christoph A Umbricht, Ulli Köster, Peter Bernhardt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 31, 2022
Preclinical investigations using [<sup>177</sup>Lu]Lu-Ibu-DAB-PSMA toward its clinical translation for radioligand therapy of prostate cancerViviane J Tschan, Francesca Borgna, Sarah D Busslinger, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 15, 2016
Left ventricular ejection fraction and presence of myocardial necrosis assessed by cardiac magnetic resonance imaging correctly risk stratify patients with stable coronary artery disease: a multi-center all-comers trialDominik Buckert, Sebastian Kelle, Sebastian Buss, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2014
Promising prospects for 44Sc-/47Sc-based theragnostics: application of 47Sc for radionuclide tumor therapy in miceCristina Müller, Maruta Bunka, Stephanie Haller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2026
Increased progression free survival with radiolabelled somatostatin receptor antagonist versus standard peptide receptor radionuclide therapy in patients with somatostatin receptor positive tumoursAbdulrafee Mushaweh, Christopher Eigler, Lisa McDougall, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2010
Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CTDamian Wild, Andreas Wicki, Rosalba Mansi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 1, 2007
Individual voxelwise dosimetry of targeted 90Y-labelled substance P radiotherapy for malignant gliomasStefan Kneifel, Peter Bernhardt, Helena Uusijärvi, et al.
Magnetic Resonance Imaging|September 10, 2017
Extent of size, shape and systolic variability of the left ventricular outflow tract in aortic stenosis determined by phase-contrast MRIFlorian Sagmeister, Markus Weininger, Sebastian Herrmann, et al.
Science China. Life Sciences|March 17, 2025
Vibration mechanics involved in buzz pollination lead to size-dependent associations between bumblebees and Pedicularis flowersYuanqing Xu, Bentao Wu, Mario Vallejo-Marín, et al.
Pageof 23

Showing results (161-170 of 224) with videos related to

Sort By:
Pageof 23
World Journal of Surgery|January 13, 2010
[177Lu-DOTA 0-Tyr 3]-octreotate treatment in patients with disseminated gastroenteropancreatic neuroendocrine tumors: the value of measuring absorbed dose to the kidneyChristina Swärd, Peter Bernhardt, Håkan Ahlman, et al.
Scientific Reports|November 30, 2019
Alpha-PET for Prostate Cancer: Preclinical investigation using <sup>149</sup>Tb-PSMA-617Christoph A Umbricht, Ulli Köster, Peter Bernhardt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 31, 2022
Preclinical investigations using [<sup>177</sup>Lu]Lu-Ibu-DAB-PSMA toward its clinical translation for radioligand therapy of prostate cancerViviane J Tschan, Francesca Borgna, Sarah D Busslinger, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 15, 2016
Left ventricular ejection fraction and presence of myocardial necrosis assessed by cardiac magnetic resonance imaging correctly risk stratify patients with stable coronary artery disease: a multi-center all-comers trialDominik Buckert, Sebastian Kelle, Sebastian Buss, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2014
Promising prospects for 44Sc-/47Sc-based theragnostics: application of 47Sc for radionuclide tumor therapy in miceCristina Müller, Maruta Bunka, Stephanie Haller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2026
Increased progression free survival with radiolabelled somatostatin receptor antagonist versus standard peptide receptor radionuclide therapy in patients with somatostatin receptor positive tumoursAbdulrafee Mushaweh, Christopher Eigler, Lisa McDougall, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2010
Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CTDamian Wild, Andreas Wicki, Rosalba Mansi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 1, 2007
Individual voxelwise dosimetry of targeted 90Y-labelled substance P radiotherapy for malignant gliomasStefan Kneifel, Peter Bernhardt, Helena Uusijärvi, et al.
Magnetic Resonance Imaging|September 10, 2017
Extent of size, shape and systolic variability of the left ventricular outflow tract in aortic stenosis determined by phase-contrast MRIFlorian Sagmeister, Markus Weininger, Sebastian Herrmann, et al.
Science China. Life Sciences|March 17, 2025
Vibration mechanics involved in buzz pollination lead to size-dependent associations between bumblebees and Pedicularis flowersYuanqing Xu, Bentao Wu, Mario Vallejo-Marín, et al.
Pageof 23